Skip to main navigation Skip to search Skip to main content

Mechanical Thrombectomy Versus Intravenous Thrombolysis in Distal Medium Vessel Acute Ischemic Stroke: A Multinational Multicenter Propensity Score-Matched Study

  • MAD MT Investigators
  • Johns Hopkins Medical Center
  • Louisiana State University System
  • Albert Einstein College of Medicine
  • Thomas Jefferson University Hospital
  • University of Massachusetts Chan Medical School
  • Department of Endovascular Neurosurgery and Neuroradiology NJMS
  • University of Massachusetts Medical Center
  • Cooper University Hospital
  • Departments of Neurological Surgery & Radiology
  • University Hospital Henri-Mondor
  • National University of Singapore
  • MD, MPH Mandy Brown Belfort, Harvard University
  • St. Michael's Hospital
  • Harvard Medical School
  • University Hospital of Limoges
  • UTHealth McGovern Medical School
  • Oregon Health and Science University
  • University Hospital of Bordeaux
  • Interventistica Neurovascolare
  • Centro Hospitalar Universitário do Porto
  • University of Cincinnati Medical Center
  • Montpellier University Medical Center
  • Tokyo Metropolitan Tama Medical Center
  • University of Southern California (USC)
  • Westchester Medical Center at New York Medical College
  • Tufts Medical Center, Boston, USA, Department of Neurosurgery. Prof. Dr. Adel Malek
  • Cedars-Sinai Medical Center
  • Sektion Vaskuläre und Interventionelle Neuroradiologie
  • Nancy University Hospital
  • University Medical Center Münster

Research output: Contribution to journal › Original Article › peer-review

33 Citations (Web of Science)

Abstract

Background and Purpose The management of acute ischemic stroke (AIS) due to distal medium vessel occlusion (DMVO) remains uncertain, particularly in comparing the effectiveness of intravenous thrombolysis (IVT) plus mechanical thrombectomy (MT) versus IVT alone. This study aimed to evaluate the safety and efficacy in DMVO patients treated with either MT-IVT or IVT alone. Methods This multinational study analyzed data from 37 centers across North America, Asia, and Europe. Patients with AIS due to DMVO were included, with data collected from September 2017 to July 2023. The primary outcome was functional independence, with secondary outcomes including mortality and safety measures such as types of intracerebral hemorrhage. Results The study involved 1,057 patients before matching, and 640 patients post-matching. Functional outcomes at 90 days showed no significant difference between groups in achieving good functional recovery (modified Rankin Scale 0-1 and 0-2), with adjusted odds ratios (OR) of 1.21 (95% confidence interval [CI] 0.81 to 1.79; P =0.35) and 1.00 (95% CI 0.66 to 1.51; P >0.99), respectively. Mortality rates at 90 days were similar between the two groups (OR 0.75, 95% CI 0.44 to 1.29; P =0.30). The incidence of symptomatic intracerebral hemorrhage was comparable, but any type of intracranial hemorrhage was significantly higher in the MT-IVT group (OR 0.43, 95% CI 0.29 to 0.63; P <0.001). Conclusion The results of this study indicate that while MT-IVT and IVT alone show similar functional and mortality outcomes in DMVO patients, MT-IVT presents a higher risk of hemorrhagic complications, thus MT-IVT may not routinely offer additional benefits over IVT alone for all DMVO stroke patients. Further prospective randomized trials are needed to identify patient subgroups most likely to benefit from MT-IVT treatment in DMVO.
Original languageEnglish
Pages (from-to)434-445
Number of pages16
JournalJOURNAL OF STROKE
Volume26
Issue number3
DOIs
Publication statusPublished - Sept 2024

Keywords

  • Distal medium vessel occlusions
  • Mechanical thrombectomy
  • Stroke

Fingerprint

Dive into the research topics of 'Mechanical Thrombectomy Versus Intravenous Thrombolysis in Distal Medium Vessel Acute Ischemic Stroke: A Multinational Multicenter Propensity Score-Matched Study'. Together they form a unique fingerprint.

Cite this